Article
A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1.
American journal of medical genetics. Part A - 1 Mar 2013
Muram Talia M, Stevenson David A, Watts-Justice Sarah, Viskochil David H, Carey John C, Mao Rong, Jackson Brian
Abstract excerpt
Neurofibromatosis type 1 (NF1) is a clinically diagnosed autosomal dominant disorder requiring routine clinical management, particularly during the pediatric years. An overlapping disorder, Legius syndrome, at times is clinically indistinguishable from NF1 and results in a small percentage of individuals being mischaracterized. Distinguishing these two entities is increasingly important for prognosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
